טוען...
CAR T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
Immunotherapy with T cells genetically modified to express chimeric antigen receptors (CARs) that target tumor-associated molecules have impressive efficacy in hematological malignancies. The field has now embraced the challenge of applying this approach to treat common epithelial malignancies, whic...
שמור ב:
| הוצא לאור ב: | J Immunol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5957501/ https://ncbi.nlm.nih.gov/pubmed/29311388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1701155 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|